Emerging Infectious Diseases (Jan 2022)

Low Seroprevalence among Undetected COVID-19 Cases, Faroe Islands, November 2020

  • Maria Skaalum Petersen,
  • Marin Strøm,
  • Jógvan Páll Fjallsbak,
  • Jóhanna Ljósá Hansen,
  • Sólrun Larsen,
  • Eina H. Eliasen,
  • Malan Johansen,
  • Anna Sofía Veyhe,
  • Marnar Fríðheim Kristiansen,
  • Pál Weihe

DOI
https://doi.org/10.3201/eid2801.210917
Journal volume & issue
Vol. 28, no. 1
pp. 242 – 244

Abstract

Read online

We conducted a second nationwide severe acute respiratory syndrome coronavirus 2 seroprevalence study in the Faroe Islands during November 2020. We found crude seroprevalence was 0.3% and prevalence was 0.4% after adjusting for test sensitivity and specificity. This low seroprevalence supports the prevention strategies used in the Faroe Islands.

Keywords